Synopsys Stock: Sales Up 46%, Margin Down To 11%

SNPSYTD-6.0%SPYYTD+9.4%QQQYTD+8.1%
Analyze SNPS →

For questions about this article or underlying research, email help@trefis.com.

Synopsys (SNPS) saw its sales grow 46.3% to $9.42 billion over the twelve months ended July 2026. Shareholders should worry about how little of that money remained as operating profit. Its operating margin as reported was 11.0% over those twelve months, down from 17.2% a year earlier. Sales are climbing fast, so why is Synopsys keeping less of each dollar?

Image from Pixabay

Synopsys Is Paying To Combine With Ansys

Synopsys is spending to bring Ansys into the company, about a year after the two combined. Ansys brought in about $711 million of the $2.477 billion in revenue Synopsys reported for fiscal Q3 2026, management said on the August 26, 2026 call. Leaving out Ansys, revenue for fiscal Q3 2026 comes to about $1.77 billion. That is close to the $1.74 billion of fiscal Q3 2025. Management also said its GAAP costs for fiscal 2026 include higher charges for its restructuring program, as the company speeds up the cost savings it committed to when the deal closed.

Gross margin has also declined, falling to 72.4% over the twelve months ended July 2026 from 79.1% a year earlier. This leaves Synopsys keeping less of each sale even before paying for its overhead.

Synopsys’s Margin Now Sits Near A Ten-Year Low

The operating margin at Synopsys has fallen two years in a row, dropping from 24.6% over the twelve months ended July 2024. Since fiscal Q4 2016, the twelve-month margin has been lower at only one quarter end, dipping to 9.7% in fiscal Q2 2026.

This trend shows up in profit dollars. Synopsys generated $1.04 billion of operating income over the twelve months ended July 2026, against $1.1 billion a year earlier even with the jump in sales. Investors still pay 9.0 times sales for Synopsys stock, against 3.2 for the S&P 500, so the price likely assumes the margin climbs back.

Where Synopsys Holders Can Find Some Comfort

The latest quarter looked better. Synopsys’s operating margin was 14.5% in fiscal Q3 2026, against 9.5% in the same quarter a year earlier and 10.4% just one quarter before.

Cash also tells a better story than the margin. Cash from operations reached $2.94 billion over the twelve months ended July 2026, against $1.44 billion a year earlier. Management said on the August call that Synopsys is ahead of schedule on the cost savings it promised when the Ansys deal closed and has repaid its term loans earlier than planned. It also said Synopsys remains committed to $400 million in synergies in the fourth year after the deal, a pledge it made while saying its joint products with Ansys will add to growth in 2027.

So the worry is real but measured. Synopsys keeps far less of its sales than it did two years ago, yet its latest quarter and its cash flow point the other way. Synopsys is expected to report its next results in December 2026, and its twelve-month operating margin as reported is the number to watch.

A company can spend years working through a deal this size. That is a good reason to settle in advance how much of your money one stock should carry and when you would step away from it.

Too Much Riding On One Stock?

If Synopsys is a big part of your wealth, so are its risk and its tax bill. What’s your exit plan? Our partner advisory firm offers a free 30-minute strategy review covering a floor under losses and a lower-tax way out.

Map My Exit Options

Spot an error or want more like this? Tell us in 10 seconds.